Home Cart 0 Sign in  

[ CAS No. 27329-70-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 27329-70-0
Chemical Structure| 27329-70-0
Structure of 27329-70-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 27329-70-0 ]

Related Doc. of [ 27329-70-0 ]

Alternatived Products of [ 27329-70-0 ]

Product Details of [ 27329-70-0 ]

CAS No. :27329-70-0 MDL No. :MFCD01114696
Formula : C5H5BO4 Boiling Point : -
Linear Structure Formula :- InChI Key :JUWYQISLQJRRNT-UHFFFAOYSA-N
M.W : 139.90 Pubchem ID :2734355
Synonyms :

Calculated chemistry of [ 27329-70-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 33.92
TPSA : 70.67 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : -0.28
Log Po/w (WLOGP) : -1.23
Log Po/w (MLOGP) : -2.29
Log Po/w (SILICOS-IT) : -1.09
Consensus Log Po/w : -0.98

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.77
Solubility : 23.8 mg/ml ; 0.17 mol/l
Class : Very soluble
Log S (Ali) : -0.74
Solubility : 25.2 mg/ml ; 0.18 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.42
Solubility : 52.8 mg/ml ; 0.378 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.56

Safety of [ 27329-70-0 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P362+P364-P403+P233-P501 UN#:3077
Hazard Statements:H315-H318-H335-H411 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 27329-70-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 27329-70-0 ]
  • Downstream synthetic route of [ 27329-70-0 ]

[ 27329-70-0 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 27329-70-0 ]
  • [ 52938-97-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6384 - 6393,10
  • 2
  • [ 637-87-6 ]
  • [ 27329-70-0 ]
  • [ 34035-03-5 ]
YieldReaction ConditionsOperation in experiment
95% With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,2-dimethoxyethane; ethanol; water at 65℃; for 1 h; General procedure: 1.00 mmol arylhalide, 1.30 mmol furfural-boronic acid and 0.05 mmolBis(triphenylphosphine)palladium(II) dichloride were treated with 0.30 mLdimethoxyethane, 0.50 mL ethanol and 0.30 mL aqueous 2M sodium carbonate solution.The reaction was heated to 65°C for 1h or until the TLC showed no remaining startingmaterial. The mixture was evaporated and extracted three times with ethyl acetate. Thecombined organic layers were washed with brine, dried over MgSO4, filtered andconcentrated. The crude product was purified by column chromatography usinghexanes/ethyl acetate (9:1).
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 126, p. 929 - 936
[2] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
  • 3
  • [ 106-39-8 ]
  • [ 27329-70-0 ]
  • [ 34035-03-5 ]
YieldReaction ConditionsOperation in experiment
63% With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,2-dimethoxyethane; ethanol; water at 60℃; for 2 h; General procedure: To a solution of 1-bromo-4-chlorobenzene (478 mg, 2.50 mmol) in a mixture of DME (7.5 mL) and EtOH (5.0 mL) were added PdCl2(PPh3)2 (36.5 mg, 52.0 μmol), 5-formyl-2-furanboronic acid (365 mg, 2.61 mmol), and 2 M aqueous Na2CO3 solution. The reaction mixture was stirred for 2 h at 60 °C, then cooled to room temperature, and volatile materials were removed under reduced pressure. To the obtained residue was added H2O and the resulting mixture was extracted with EtOAc. The organic layer was washed with brine, dried over MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc = 5:1) to afford 19e (323 mg, 63percent) as a yellow solid. 1H NMR (500 MHz, CDCl3) δ 9.64 (1H, s), 7.73 (2H, d, J = 8.5 Hz), 7.40 (2H, d, J = 8.5 Hz), 7.30 (1H, d, J = 3.6 Hz), 6.81 (1H, d, J = 3.6 Hz); MS (FAB) m/z 207 (M+H)+.
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6384 - 6393,10
[2] Organic and Biomolecular Chemistry, 2012, vol. 10, # 36, p. 7402 - 7417
  • 4
  • [ 27329-70-0 ]
  • [ 586-78-7 ]
  • [ 7147-77-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 36, p. 7402 - 7417
  • 5
  • [ 636-98-6 ]
  • [ 27329-70-0 ]
  • [ 7147-77-5 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
[2] Chemical Biology and Drug Design, 2018, vol. 91, # 1, p. 257 - 268
  • 6
  • [ 27329-70-0 ]
  • [ 589-87-7 ]
  • [ 20005-42-9 ]
YieldReaction ConditionsOperation in experiment
85% With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,2-dimethoxyethane; ethanol; water at 65℃; for 1 h; General procedure: 1.00 mmol arylhalide, 1.30 mmol furfural-boronic acid and 0.05 mmolBis(triphenylphosphine)palladium(II) dichloride were treated with 0.30 mLdimethoxyethane, 0.50 mL ethanol and 0.30 mL aqueous 2M sodium carbonate solution.The reaction was heated to 65°C for 1h or until the TLC showed no remaining startingmaterial. The mixture was evaporated and extracted three times with ethyl acetate. Thecombined organic layers were washed with brine, dried over MgSO4, filtered andconcentrated. The crude product was purified by column chromatography usinghexanes/ethyl acetate (9:1).
68%
Stage #1: With bis-triphenylphosphine-palladium(II) chloride In 1,2-dimethoxyethane; ethanol for 0.5 h;
Stage #2: With sodium carbonate In 1,2-dimethoxyethane; ethanol; water for 12 h; Reflux
General procedure: Method A: To a solution of 3a (150 mg, 0.47 mmol) in a mixture of dry DME (3 mL) and dry EtOH (3 mL), bis(triphenylphosphine)palladium(II) dichloride (17 mg, 0.02 mmol) was added. After 30 min, a solution of sodium carbonate (299 mg, 2.82 mmol) in H2O(2 mL) and a solution of 5-formyl-2-furanylboronic acid 4 (93 mg,0.66 mmol) in dry EtOH (1.5 mL) were added in this order. The reaction was heated under reflux for 12 h. After this time, H2O (4 mL)was added at 25 C and the organic phase was extracted with EtOAc(3 5 mL), dried over sodium sulfate, filtered and evaporated in vacuo. The crude product was purified by flash chromatography on silica gel (2percent EtOAc in petroleum ether) to give 5a as orange solid(79 mg, 60percent). Method B: To a suspension of 16a (1.0 g, 4.8 mmol) in H2O (20 mL), HCl (37percent, 2 mL) was added. The resulting solution was cooled at 0 C and a solution of sodium nitrite (397 mg, 5.76 mmol) in H2O (2 mL) was added dropwise. After 1 h, a solution of 17(400 mL, 4.8 mmol) in acetone (2 mL) and solid copper(II) chloride(128 mg, 0.96 mmol) were added. The mixture kept at 25 C for 12 h. EtOAc was added (3 10 mL) and the organic phase was separated, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product was purified by flash chromatography on silica gel (2percent EtOAc in petroleum ether) to give 5a as orange solid(1.23 g, 90percent).
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 126, p. 929 - 936
[2] European Journal of Medicinal Chemistry, 2018, vol. 150, p. 698 - 718
  • 7
  • [ 27329-70-0 ]
  • [ 106-37-6 ]
  • [ 20005-42-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 36, p. 7402 - 7417
  • 8
  • [ 27329-70-0 ]
  • [ 619-44-3 ]
  • [ 53355-29-6 ]
YieldReaction ConditionsOperation in experiment
75% With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate In 1,4-dioxane; water at 100℃; Inert atmosphere General procedure: A mixture of substituted iodobenzene (2 mmol), (5-formylfuran-2-yl)boronic acid (420 mg, 3mmol, 1.5 equiv), Pd(Ph3P)2Cl2 (0.1 mmol, 0.05 equiv, 70 mg) and potassium carbonate (6 mmol,3 equiv, 828 mg) in dioxone/H2O (6 mL/2 mL) was stirred at 100 °C under argon atmosphereuntil the starting material was consumed (typically 20 h). The reaction mixture was then diluted with 25 mL of saturated brine. The mixture was then extracted with EtOAc (25 mL × 2), and the organic layers were combined, dried over Na2SO4. The concentrated crude product was purifie dby column chromatography to afford c2a-e. The second step is the same as procedure A.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 6, p. 1024 - 1029
[2] Patent: CN106977474, 2017, A, . Location in patent: Paragraph 0034; 0037; 0038
[3] Chemical Biology and Drug Design, 2018, vol. 91, # 1, p. 257 - 268
  • 9
  • [ 27329-70-0 ]
  • [ 619-42-1 ]
  • [ 53355-29-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 17, p. 4585 - 4600
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 13, p. 2159 - 2161
  • 10
  • [ 13529-27-6 ]
  • [ 27329-70-0 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With Triisopropyl borate; lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -10 - 0℃; for 1 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; n-heptane; ethylbenzene; water at 30℃;
A dried 500 mL 3-neck flask with mechanical stirrer, internal thermometer and addition funnel under nitrogen is charged with 20,16 g (0,118 mol) furfuraldiethylacetal, 33,4 g (0,177 mol) triisopropylborate and 40 mL of anhydrous THF. The water content of the reaction mixture was measured according to the Karl-Fischer-titration method and was determined to be less than 800 μg/mL of water. The solution is cooled to an internal temperature of -10°C. Keeping the temperature at -10°C to 0°C 84 mL (25 wtpercent, 1.84 M solution THF, heptane, ethylbenzene from Chemmetal, content determined by titration, 1.3 equivalents) LDA was added via addition funnel to the reaction mixture over a period of 1 hour. Using a canula the reaction mixture was subsequently transferred to precooled aqueous hydrochloric acid which was obtained by mixing 33 mL of concentrated hydrochloric acid and 55 mL water. The reaction temperature was maintained at a temperature of less than 30°C. The resulting tan slurry of 5-formyl-2-furylboronic acid was cooled to 0°C and filtered. The filter cake was washed twice with 20 mL of cold water to give 17.6 g of wet cake. Drying (40°C, vacuum oven) gave 12.41 g of an off-white product. The overall yield of 5-formyl-2-furylboronic acid was 75percent. The content of unreacted furfural in the crude product was determined to be less than 0,1percent.
Reference: [1] Patent: EP1403271, 2004, A1, . Location in patent: Page 3, 4
[2] Organic and Biomolecular Chemistry, 2003, vol. 1, # 9, p. 1447 - 1449
  • 11
  • [ 13529-27-6 ]
  • [ 121-43-7 ]
  • [ 27329-70-0 ]
Reference: [1] Patent: WO2004/24738, 2004, A1, . Location in patent: Page/Page column 13
[2] Organic and Biomolecular Chemistry, 2003, vol. 1, # 9, p. 1447 - 1449
  • 12
  • [ 1708-41-4 ]
  • [ 27329-70-0 ]
Reference: [1] Patent: US2009/131685, 2009, A1, . Location in patent: Page/Page column 9
[2] Patent: US2009/131685, 2009, A1, . Location in patent: Page/Page column 8-9
[3] Patent: US2009/131685, 2009, A1, . Location in patent: Page/Page column 9
[4] Patent: US2009/131685, 2009, A1, . Location in patent: Page/Page column 9
  • 13
  • [ 1899-24-7 ]
  • [ 5419-55-6 ]
  • [ 27329-70-0 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 585 - 598
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 27329-70-0 ]

Organoboron

Chemical Structure| 62306-79-0

[ 62306-79-0 ]

(5-Methylfuran-2-yl)boronic acid

Similarity: 0.88

Chemical Structure| 1256355-56-2

[ 1256355-56-2 ]

(5-(Hydroxymethyl)furan-2-yl)boronic acid

Similarity: 0.81

Chemical Structure| 1150114-44-5

[ 1150114-44-5 ]

(5-(Ethoxycarbonyl)furan-2-yl)boronic acid

Similarity: 0.81

Chemical Structure| 13331-23-2

[ 13331-23-2 ]

Furan-2-ylboronic acid

Similarity: 0.74

Chemical Structure| 338998-93-9

[ 338998-93-9 ]

4,4,5,5-Tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane

Similarity: 0.65

Aldehydes

Chemical Structure| 62306-80-3

[ 62306-80-3 ]

(5-Formylfuran-3-yl)boronic acid

Similarity: 0.58

Chemical Structure| 823-82-5

[ 823-82-5 ]

Furan-2,5-dicarbaldehyde

Similarity: 0.55

Chemical Structure| 13529-17-4

[ 13529-17-4 ]

5-Formylfuran-2-carboxylic acid

Similarity: 0.50

Related Parent Nucleus of
[ 27329-70-0 ]

Furans

Chemical Structure| 62306-79-0

[ 62306-79-0 ]

(5-Methylfuran-2-yl)boronic acid

Similarity: 0.88

Chemical Structure| 1256355-56-2

[ 1256355-56-2 ]

(5-(Hydroxymethyl)furan-2-yl)boronic acid

Similarity: 0.81

Chemical Structure| 1150114-44-5

[ 1150114-44-5 ]

(5-(Ethoxycarbonyl)furan-2-yl)boronic acid

Similarity: 0.81

Chemical Structure| 13331-23-2

[ 13331-23-2 ]

Furan-2-ylboronic acid

Similarity: 0.74

Chemical Structure| 338998-93-9

[ 338998-93-9 ]

4,4,5,5-Tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane

Similarity: 0.65